Partnerships

We focus on clinic-ready compounds and can accommodate a wide range of partnering structures. Our approach allows us to determine the best drug candidates without any inherent internal biases, thus circumventing the potential challenges and low probabilities of success associated with early research efforts. 

Contact us at oib.e1748467223rof@r1748467223entra1748467223p1748467223 to discuss a potential collaboration.